Arizona State Retirement System’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.9M	Sell	35,899 -491	-1%	-$167K	0.07%	234
2025 Q4	$14.5M	Sell	36,390 -2,122	-6%	-$939K	0.08%	204
2025 Q3	$17.6M	Buy	38,512 +584	+2%	+$238K	0.09%	178
2025 Q2	$12.4M	Buy	37,928 +680	+2%	+$188K	0.07%	240
2025 Q1	$10.1M	Buy	37,248 +44	+0.1%	+$11.3K	0.06%	258
2024 Q4	$8.75M	Buy	37,204 +964	+3%	+$254K	0.05%	300
2024 Q3	$9.97M	Buy	36,240 +1,504	+4%	+$392K	0.06%	275
2024 Q2	$8.44M	Buy	34,736 +219	+0.6%	+$34.6K	0.06%	286
2024 Q1	$5.16M	Buy	34,517 +161	+0.5%	+$26.9K	0.04%	398
2023 Q4	$6.58M	Buy	34,356 +383	+1%	+$65.2K	0.05%	326
2023 Q3	$6.02M	Buy	33,973 +153	+0.5%	+$29.2K	0.05%	323
2023 Q2	$6.42M	Sell	33,820 -1,947	-5%	-$386K	0.05%	327
2023 Q1	$7.16M	Buy	35,767 +1,793	+5%	+$377K	0.06%	300
2022 Q4	$8.07M	Buy	33,974 +803	+2%	+$171K	0.08%	255
2022 Q3	$6.64M	Sell	33,171 -379	-1%	-$72.3K	0.07%	274
2022 Q2	$4.89M	Buy	33,550 +258	+0.8%	+$36.6K	0.05%	360
2022 Q1	$5.44M	Buy	33,292 +933	+3%	+$142K	0.04%	378
2021 Q4	$5.49M	Sell	32,359 -629	-2%	-$117K	0.04%	394
2021 Q3	$6.23M	Sell	32,988 -82	-0.2%	-$15.4K	0.05%	341
2021 Q2	$5.61M	Sell	33,070 -428	-1%	-$62.7K	0.05%	382
2021 Q1	$4.73M	Buy	33,498 +243	+0.7%	+$36.6K	0.04%	423
2020 Q4	$4.32M	Sell	33,255 -1,683	-5%	-$225K	0.04%	414
2020 Q3	$5.09M	Buy	34,938 +8,713	+33%	+$1.24M	0.05%	328
2020 Q2	$3.88M	Buy	26,225 +568	+2%	+$76.6K	0.05%	316
2020 Q1	$2.79M	Buy	+25,657	New	+$2.96M	0.05%	393